Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 24 studies | 29% ± 10% | |
endothelial cell | 18 studies | 30% ± 11% | |
pericyte | 17 studies | 49% ± 21% | |
smooth muscle cell | 16 studies | 45% ± 19% | |
astrocyte | 12 studies | 31% ± 17% | |
capillary endothelial cell | 10 studies | 42% ± 18% | |
endothelial cell of artery | 7 studies | 50% ± 26% | |
vein endothelial cell | 6 studies | 37% ± 21% | |
myofibroblast cell | 5 studies | 33% ± 8% | |
enterocyte | 5 studies | 31% ± 14% | |
endothelial cell of vascular tree | 5 studies | 51% ± 18% | |
glomerular endothelial cell | 4 studies | 53% ± 2% | |
goblet cell | 4 studies | 30% ± 15% | |
transit amplifying cell | 4 studies | 30% ± 17% | |
adventitial cell | 4 studies | 44% ± 7% | |
mesothelial cell | 4 studies | 49% ± 16% | |
epithelial cell | 4 studies | 34% ± 12% | |
hepatocyte | 4 studies | 65% ± 27% | |
luminal cell of prostate epithelium | 4 studies | 26% ± 5% | |
intestinal crypt stem cell | 3 studies | 41% ± 19% | |
adipocyte | 3 studies | 19% ± 1% | |
Mueller cell | 3 studies | 35% ± 24% | |
connective tissue cell | 3 studies | 37% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 88% | 1777.75 | 2317 / 2642 | 96% | 99.28 | 676 / 705 |
prostate | 78% | 1580.04 | 191 / 245 | 91% | 115.70 | 459 / 502 |
pancreas | 74% | 1406.39 | 243 / 328 | 91% | 59.43 | 162 / 178 |
thymus | 88% | 1773.75 | 577 / 653 | 52% | 24.93 | 314 / 605 |
lung | 90% | 3023.45 | 521 / 578 | 46% | 15.38 | 528 / 1155 |
liver | 92% | 7851.00 | 209 / 226 | 43% | 139.72 | 174 / 406 |
stomach | 92% | 1933.21 | 329 / 359 | 40% | 12.91 | 115 / 286 |
breast | 93% | 3678.58 | 427 / 459 | 35% | 16.02 | 387 / 1118 |
kidney | 65% | 1004.08 | 58 / 89 | 39% | 28.90 | 349 / 901 |
intestine | 58% | 919.03 | 557 / 966 | 45% | 21.46 | 239 / 527 |
skin | 64% | 877.54 | 1156 / 1809 | 38% | 19.92 | 181 / 472 |
adipose | 97% | 6103.12 | 1167 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 94% | 2519.65 | 1252 / 1335 | 0% | 0 | 0 / 0 |
bladder | 57% | 707.43 | 12 / 21 | 33% | 17.10 | 165 / 504 |
uterus | 34% | 477.16 | 57 / 170 | 54% | 26.00 | 247 / 459 |
esophagus | 49% | 674.19 | 710 / 1445 | 32% | 15.59 | 59 / 183 |
ovary | 26% | 294.57 | 47 / 180 | 49% | 25.34 | 211 / 430 |
adrenal gland | 29% | 216.97 | 76 / 258 | 27% | 15.29 | 62 / 230 |
lymph node | 0% | 0 | 0 / 0 | 52% | 32.70 | 15 / 29 |
tonsil | 0% | 0 | 0 / 0 | 47% | 18.21 | 21 / 45 |
heart | 35% | 419.77 | 299 / 861 | 0% | 0 | 0 / 0 |
muscle | 34% | 632.71 | 277 / 803 | 0% | 0 | 0 / 0 |
spleen | 11% | 69.23 | 26 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 10% | 3.51 | 8 / 80 |
peripheral blood | 2% | 51.17 | 19 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071294 | Biological process | cellular response to zinc ion |
GO_0071276 | Biological process | cellular response to cadmium ion |
GO_0071280 | Biological process | cellular response to copper ion |
GO_0010273 | Biological process | detoxification of copper ion |
GO_0045926 | Biological process | negative regulation of growth |
GO_0006882 | Biological process | intracellular zinc ion homeostasis |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | MT1M |
Protein name | Metallothionein Metallothionein-1M (MT-1M) (Metallothionein-IM) (MT-IM) |
Synonyms | MT1K |
Description | FUNCTION: Metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids. FUNCTION: Metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids. . |
Accessions | ENST00000379818.4 ENST00000570233.1 Q8N339 H3BUC6 |